View ValuationMothercare 将来の成長Future 基準チェック /06Mothercareの収益は年間72.5%で減少すると予測されていますが、年間収益は年間2.7%で増加すると予想されています。EPS は年間72.9%で減少すると予想されています。主要情報-72.5%収益成長率-72.94%EPS成長率Specialty Retail 収益成長30.7%収益成長率2.7%将来の株主資本利益率n/aアナリストカバレッジLow最終更新日13 Apr 2026今後の成長に関する最新情報お知らせ • Mar 10Mothercare plc Announces Suspension of Operations in RussiaMothercare plc announced that all business in Russia, including shipment of all products has been suspended. Local partner has confirmed that it will be immediately pausing operations in some 120 stores and online.すべての更新を表示Recent updatesNew Risk • Jul 12New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Share price has been highly volatile over the past 3 months (79% average daily change). Negative equity (-UK£10m). Earnings are forecast to decline by an average of 72% per year for the foreseeable future. Market cap is less than US$10m (€4.63m market cap, or US$5.29m). Minor Risk Latest financial reports are more than 6 months old (reported September 2025 fiscal period end).Board Change • May 20Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 2 highly experienced directors. CFO, Member of Operating Board & Director Andy Cook was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.お知らせ • Sep 26Mothercare plc, Annual General Meeting, Nov 12, 2025Mothercare plc, Annual General Meeting, Nov 12, 2025. Location: westside 1, london road, hp3 9td, hemel hempstead United Kingdomお知らせ • Nov 22Mothercare plc Announces Resignation of Mark Newton from the BoardMothercare plc announced upon Clive Whiley’s appointment as Chairman, Mark Newton Jones agreed to return to the board as a non-executive director to lend his support to the Transformation Plan and subsequently the actions necessary to combat the impact of the pandemic and the Ukraine conflict on the business. Accordingly, following creation of the new India joint venture and coterminous refinancing, Mark had indicated his intention to stand down from the board at its AGM and has now resigned as a director.お知らせ • Oct 22Mothercare plc, Annual General Meeting, Nov 19, 2024Mothercare plc, Annual General Meeting, Nov 19, 2024. Location: westside 1, london road, hp3 9td, hemel hempstead United KingdomReported Earnings • Oct 19Full year 2024 earnings released: EPS: UK£0.006 (vs UK£0 in FY 2023)Full year 2024 results: EPS: UK£0.006 (up from UK£0 in FY 2023). Revenue: UK£56.2m (down 23% from FY 2023). Net income: UK£3.30m (up UK£3.40m from FY 2023). Profit margin: 5.9% (up from net loss in FY 2023). The move to profitability was driven by lower expenses. Revenue is expected to decline by 1.4% p.a. on average during the next 3 years, while revenues in the Specialty Retail industry in Germany are expected to grow by 5.8%. Over the last 3 years on average, earnings per share has increased by 82% per year but the company’s share price has fallen by 51% per year, which means it is significantly lagging earnings.New Risk • Jun 11New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.9x net interest cover). Share price has been highly volatile over the past 3 months (13% average weekly change). Negative equity (-UK£13m). High level of non-cash earnings (23% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported September 2023 fiscal period end). Profit margins are more than 30% lower than last year (1.9% net profit margin). Market cap is less than US$100m (€31.1m market cap, or US$33.4m).Reported Earnings • Nov 29First half 2024 earnings released: EPS: UK£0.003 (vs UK£0.001 in 1H 2023)First half 2024 results: EPS: UK£0.003 (up from UK£0.001 in 1H 2023). Revenue: UK£29.0m (down 25% from 1H 2023). Net income: UK£1.70m (up 325% from 1H 2023). Profit margin: 5.9% (up from 1.0% in 1H 2023). The increase in margin was driven by lower expenses. Revenue is forecast to grow 2.2% p.a. on average during the next 3 years, compared to a 6.5% growth forecast for the Specialty Retail industry in Germany. Over the last 3 years on average, earnings per share has increased by 110% per year but the company’s share price has fallen by 30% per year, which means it is significantly lagging earnings.New Risk • Nov 25New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 2.3x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.3x net interest cover). Share price has been highly volatile over the past 3 months (22% average weekly change). Negative equity (-UK£13m). High level of non-cash earnings (23% accrual ratio). Minor Risks Profit margins are more than 30% lower than last year (1.9% net profit margin). Market cap is less than US$100m (€34.4m market cap, or US$37.7m).お知らせ • Sep 27Mothercare plc, Annual General Meeting, Oct 23, 2023Mothercare plc, Annual General Meeting, Oct 23, 2023, at 10:00 Coordinated Universal Time. Location: Westside 1, London Road Hemel Hemsptead United Kingdom Agenda: To receive the Company's annual accounts, together with the directors' report, the strategic report, the directors' remuneration report and the auditors' report for the 52 weeks ended 25 March 2023; to approve the directors' remuneration report for the 52 weeks ended 25 March 2023; to re-elect Clive Whiley as a director of the Company; to re-elect Andrew Cook as a director of the Company; to re-elect Gillian Kent as a director of the Company; to re-elect Mark Newton-Jones as a director of the Company; to re-elect Brian Small as a director of the Company and to consider other business matters.Recent Insider Transactions • Sep 24Non-Executive Chairman recently bought €54k worth of stockOn the 22nd of September, Clive Whiley bought around 946k shares on-market at roughly €0.058 per share. This transaction amounted to 31% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Clive has been a buyer over the last 12 months, purchasing a net total of €128k worth in shares.お知らせ • Jun 09+ 1 more updateMothercare plc Daniel Le Vesconte to Step Down from His Role as Director of the BoardMothercare plc announces that Daniel Le Vesconte has stepped down from his role as Chief Executive Officer ("CEO") and as a Director of the Board with immediate effect. Clive Whiley, the Company's Chairman and Andrew Cook, the CFO, will revert to leading the Operating Board, as was the case for the previous three years, until the process to find a replacement CEO is completed.Board Change • Mar 12Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Independent Non Executive Director Brian Small was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • Oct 27Jamilco Reportedly Wants to Buy Mothercare Assets in RussiaMfk Dzhamilko, Ao (Jamilco) plans to buy the Russian business of Mothercare plc (AIM:MTC), which announced its withdrawal from the Russian market, business daily Kommersant reported on October 26, 2022 citing three sources in the retail market. According to the sources, the distributor is in talks with the Kuwaiti company M.H. Alshaya Co. W.L.L. (Alshaya Group), which owns the master franchise brand Mothercare in Russia. According to one of the daily's interlocutors, as a part of the deal Jamilco will receive the lease rights for the stores of the Mothercare brand, as well as unsold goods. At the same time the stores will operate under a different brand.お知らせ • Sep 17Mothercare plc, Annual General Meeting, Oct 13, 2022Mothercare plc, Annual General Meeting, Oct 13, 2022, at 10:00 Coordinated Universal Time. Location: Westside 1, London Road, Hemel Hempstead, HP3 9TD Hempstead United Kingdom Agenda: To receive the Company's annual accounts, together with the directors' report, the strategic report, the directors' remuneration report and the auditors' report for the 52 weeks ended 26 March 2022; to approve the directors' remuneration report for the 52 weeks ended 26 March 2022, which includes the directors' remuneration policy which will take effect immediately after the end of the annual general meeting of the Company on 13 October 2022; to re-elect Clive Whiley as a director of the Company; to re-elect Andrew Cook as a director of the Company; to re-elect Gillian Kent as a director of the Company; to re-elect Mark Newton-Jones as a director of the Company; to re-elect Brian Small as a director of the Company; and to transact other business.お知らせ • Mar 10Mothercare plc Announces Suspension of Operations in RussiaMothercare plc announced that all business in Russia, including shipment of all products has been suspended. Local partner has confirmed that it will be immediately pausing operations in some 120 stores and online.お知らせ • Mar 14Mothercare plc(AIM:MTC) dropped from FTSE All-Small Index (GBP)Mothercare plc(AIM:MTC) dropped from FTSE All-Small Index (GBP)お知らせ • Mar 12Mothercare Ordinary Shares to Trading on the Main Market of London Stock Exchange Premium Listing Segment of the Official List to Be CancelledMothercare plc announced that an application has been made to The London Stock Exchange for a block listing of 23,356,329 ordinary shares of 1 pence each in the Company ("Ordinary Shares") to be admitted to trading on AIM. Following the General Meeting held on 10 February 2021, the Company expects the admission of the Company's Ordinary Shares to trading on AIM to become effective at 8.00 a.m. on 12 March 2021. Simultaneously, the admission of the Ordinary Shares to trading on the Main Market of London Stock Exchange plc and to the premium listing segment of the Official List will be cancelled.お知らせ • Jan 26Mothercare Announces Proposal to Delist Application to Admission to AIMFurther to the announcement on 26 November 2020 Mothercare plc sets out the detailed proposals for the approval of Shareholders at a General Meeting to permit: The Delisting and the proposed application to admission to AIM.お知らせ • Jan 25Mothercare plc, Annual General Meeting, Feb 10, 2021Mothercare plc, Annual General Meeting, Feb 10, 2021, at 11:00 Coordinated Universal Time. Location: Westside 1, London Road Hemel Hempstead Herefordshire United KingdomReported Earnings • Nov 29First half 2021 earnings released: UK£0.038 loss per shareThe company reported a poor first half result with weaker earnings, revenues and control over expenses. First half 2021 results: Revenue: UK£44.4m (down 56% from 1H 2020). Net loss: UK£14.1m (down 352% from profit in 1H 2020). Over the last 3 years on average, earnings per share has increased by 71% per year but the company’s share price has fallen by 47% per year, which means it is significantly lagging earnings.Reported Earnings • Sep 28Full year earnings released - €0.02 loss per shareOver the last 12 months the company has reported total losses of UK£7.20m, with losses narrowing by 67% from the prior year. Total revenue was UK£164.7m over the last 12 months, down 18% from the prior year.業績と収益の成長予測DB:MTR - アナリストの将来予測と過去の財務データ ( )GBP Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数3/31/202832-2-1113/31/202730-31213/31/202630-3-2N/A19/27/2025306-3-2N/A6/27/2025346-3-2N/A3/29/2025396-3-1N/A12/29/202444302N/A9/28/202448035N/A6/28/202452235N/A3/30/202456335N/A12/30/202360213N/A9/23/202364102N/A6/23/202368113N/A3/25/202373024N/A12/25/202276446N/A9/24/202279958N/A6/24/2022811158N/A3/26/2022831258N/A12/26/2021834N/AN/AN/A9/25/202183-5-2-1N/A6/25/202184-13-2-2N/A3/27/202186-21-3-3N/A12/27/202096-24N/AN/AN/A10/10/2020107-2766N/A7/10/2020136-1823N/A3/28/2020165-8-11N/A12/28/201998-220N/A10/12/20193255-1N/A7/12/2019116-8N/A0N/A3/30/2019200-21N/A1N/A10/6/2018511-99N/A8N/A7/6/2018546-96N/A5N/A3/24/2018581-93N/A1N/A12/24/2017657-41N/A4N/A10/7/2017659-7N/A8N/A7/7/20176631N/A12N/A3/25/20176678N/A15N/A12/25/20166745N/A12N/A10/8/20166802N/A9N/A7/8/20166814N/A15N/A3/26/20166826N/A22N/A12/26/2015687-4N/A16N/A10/10/2015691-15N/A10N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: MTRの収益は今後 3 年間で減少すると予測されています (年間-72.5% )。収益対市場: MTRの収益は今後 3 年間で減少すると予測されています (年間-72.5% )。高成長収益: MTRの収益は今後 3 年間で減少すると予測されています。収益対市場: MTRの収益 ( 2.7% ) German市場 ( 6.6% ) よりも低い成長が予測されています。高い収益成長: MTRの収益 ( 2.7% ) 20%よりも低い成長が予測されています。一株当たり利益成長率予想将来の株主資本利益率将来のROE: MTRの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YRetail 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/07/23 01:43終値2026/07/23 00:00収益2025/09/27年間収益2025/03/29データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Mothercare plc 1 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。12 アナリスト機関Robert ChantryBerenbergSanjay VidyarthiCanaccord GenuityNigel ParsonCavendish9 その他のアナリストを表示
お知らせ • Mar 10Mothercare plc Announces Suspension of Operations in RussiaMothercare plc announced that all business in Russia, including shipment of all products has been suspended. Local partner has confirmed that it will be immediately pausing operations in some 120 stores and online.
New Risk • Jul 12New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Share price has been highly volatile over the past 3 months (79% average daily change). Negative equity (-UK£10m). Earnings are forecast to decline by an average of 72% per year for the foreseeable future. Market cap is less than US$10m (€4.63m market cap, or US$5.29m). Minor Risk Latest financial reports are more than 6 months old (reported September 2025 fiscal period end).
Board Change • May 20Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 2 highly experienced directors. CFO, Member of Operating Board & Director Andy Cook was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
お知らせ • Sep 26Mothercare plc, Annual General Meeting, Nov 12, 2025Mothercare plc, Annual General Meeting, Nov 12, 2025. Location: westside 1, london road, hp3 9td, hemel hempstead United Kingdom
お知らせ • Nov 22Mothercare plc Announces Resignation of Mark Newton from the BoardMothercare plc announced upon Clive Whiley’s appointment as Chairman, Mark Newton Jones agreed to return to the board as a non-executive director to lend his support to the Transformation Plan and subsequently the actions necessary to combat the impact of the pandemic and the Ukraine conflict on the business. Accordingly, following creation of the new India joint venture and coterminous refinancing, Mark had indicated his intention to stand down from the board at its AGM and has now resigned as a director.
お知らせ • Oct 22Mothercare plc, Annual General Meeting, Nov 19, 2024Mothercare plc, Annual General Meeting, Nov 19, 2024. Location: westside 1, london road, hp3 9td, hemel hempstead United Kingdom
Reported Earnings • Oct 19Full year 2024 earnings released: EPS: UK£0.006 (vs UK£0 in FY 2023)Full year 2024 results: EPS: UK£0.006 (up from UK£0 in FY 2023). Revenue: UK£56.2m (down 23% from FY 2023). Net income: UK£3.30m (up UK£3.40m from FY 2023). Profit margin: 5.9% (up from net loss in FY 2023). The move to profitability was driven by lower expenses. Revenue is expected to decline by 1.4% p.a. on average during the next 3 years, while revenues in the Specialty Retail industry in Germany are expected to grow by 5.8%. Over the last 3 years on average, earnings per share has increased by 82% per year but the company’s share price has fallen by 51% per year, which means it is significantly lagging earnings.
New Risk • Jun 11New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.9x net interest cover). Share price has been highly volatile over the past 3 months (13% average weekly change). Negative equity (-UK£13m). High level of non-cash earnings (23% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported September 2023 fiscal period end). Profit margins are more than 30% lower than last year (1.9% net profit margin). Market cap is less than US$100m (€31.1m market cap, or US$33.4m).
Reported Earnings • Nov 29First half 2024 earnings released: EPS: UK£0.003 (vs UK£0.001 in 1H 2023)First half 2024 results: EPS: UK£0.003 (up from UK£0.001 in 1H 2023). Revenue: UK£29.0m (down 25% from 1H 2023). Net income: UK£1.70m (up 325% from 1H 2023). Profit margin: 5.9% (up from 1.0% in 1H 2023). The increase in margin was driven by lower expenses. Revenue is forecast to grow 2.2% p.a. on average during the next 3 years, compared to a 6.5% growth forecast for the Specialty Retail industry in Germany. Over the last 3 years on average, earnings per share has increased by 110% per year but the company’s share price has fallen by 30% per year, which means it is significantly lagging earnings.
New Risk • Nov 25New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 2.3x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.3x net interest cover). Share price has been highly volatile over the past 3 months (22% average weekly change). Negative equity (-UK£13m). High level of non-cash earnings (23% accrual ratio). Minor Risks Profit margins are more than 30% lower than last year (1.9% net profit margin). Market cap is less than US$100m (€34.4m market cap, or US$37.7m).
お知らせ • Sep 27Mothercare plc, Annual General Meeting, Oct 23, 2023Mothercare plc, Annual General Meeting, Oct 23, 2023, at 10:00 Coordinated Universal Time. Location: Westside 1, London Road Hemel Hemsptead United Kingdom Agenda: To receive the Company's annual accounts, together with the directors' report, the strategic report, the directors' remuneration report and the auditors' report for the 52 weeks ended 25 March 2023; to approve the directors' remuneration report for the 52 weeks ended 25 March 2023; to re-elect Clive Whiley as a director of the Company; to re-elect Andrew Cook as a director of the Company; to re-elect Gillian Kent as a director of the Company; to re-elect Mark Newton-Jones as a director of the Company; to re-elect Brian Small as a director of the Company and to consider other business matters.
Recent Insider Transactions • Sep 24Non-Executive Chairman recently bought €54k worth of stockOn the 22nd of September, Clive Whiley bought around 946k shares on-market at roughly €0.058 per share. This transaction amounted to 31% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Clive has been a buyer over the last 12 months, purchasing a net total of €128k worth in shares.
お知らせ • Jun 09+ 1 more updateMothercare plc Daniel Le Vesconte to Step Down from His Role as Director of the BoardMothercare plc announces that Daniel Le Vesconte has stepped down from his role as Chief Executive Officer ("CEO") and as a Director of the Board with immediate effect. Clive Whiley, the Company's Chairman and Andrew Cook, the CFO, will revert to leading the Operating Board, as was the case for the previous three years, until the process to find a replacement CEO is completed.
Board Change • Mar 12Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Independent Non Executive Director Brian Small was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • Oct 27Jamilco Reportedly Wants to Buy Mothercare Assets in RussiaMfk Dzhamilko, Ao (Jamilco) plans to buy the Russian business of Mothercare plc (AIM:MTC), which announced its withdrawal from the Russian market, business daily Kommersant reported on October 26, 2022 citing three sources in the retail market. According to the sources, the distributor is in talks with the Kuwaiti company M.H. Alshaya Co. W.L.L. (Alshaya Group), which owns the master franchise brand Mothercare in Russia. According to one of the daily's interlocutors, as a part of the deal Jamilco will receive the lease rights for the stores of the Mothercare brand, as well as unsold goods. At the same time the stores will operate under a different brand.
お知らせ • Sep 17Mothercare plc, Annual General Meeting, Oct 13, 2022Mothercare plc, Annual General Meeting, Oct 13, 2022, at 10:00 Coordinated Universal Time. Location: Westside 1, London Road, Hemel Hempstead, HP3 9TD Hempstead United Kingdom Agenda: To receive the Company's annual accounts, together with the directors' report, the strategic report, the directors' remuneration report and the auditors' report for the 52 weeks ended 26 March 2022; to approve the directors' remuneration report for the 52 weeks ended 26 March 2022, which includes the directors' remuneration policy which will take effect immediately after the end of the annual general meeting of the Company on 13 October 2022; to re-elect Clive Whiley as a director of the Company; to re-elect Andrew Cook as a director of the Company; to re-elect Gillian Kent as a director of the Company; to re-elect Mark Newton-Jones as a director of the Company; to re-elect Brian Small as a director of the Company; and to transact other business.
お知らせ • Mar 10Mothercare plc Announces Suspension of Operations in RussiaMothercare plc announced that all business in Russia, including shipment of all products has been suspended. Local partner has confirmed that it will be immediately pausing operations in some 120 stores and online.
お知らせ • Mar 14Mothercare plc(AIM:MTC) dropped from FTSE All-Small Index (GBP)Mothercare plc(AIM:MTC) dropped from FTSE All-Small Index (GBP)
お知らせ • Mar 12Mothercare Ordinary Shares to Trading on the Main Market of London Stock Exchange Premium Listing Segment of the Official List to Be CancelledMothercare plc announced that an application has been made to The London Stock Exchange for a block listing of 23,356,329 ordinary shares of 1 pence each in the Company ("Ordinary Shares") to be admitted to trading on AIM. Following the General Meeting held on 10 February 2021, the Company expects the admission of the Company's Ordinary Shares to trading on AIM to become effective at 8.00 a.m. on 12 March 2021. Simultaneously, the admission of the Ordinary Shares to trading on the Main Market of London Stock Exchange plc and to the premium listing segment of the Official List will be cancelled.
お知らせ • Jan 26Mothercare Announces Proposal to Delist Application to Admission to AIMFurther to the announcement on 26 November 2020 Mothercare plc sets out the detailed proposals for the approval of Shareholders at a General Meeting to permit: The Delisting and the proposed application to admission to AIM.
お知らせ • Jan 25Mothercare plc, Annual General Meeting, Feb 10, 2021Mothercare plc, Annual General Meeting, Feb 10, 2021, at 11:00 Coordinated Universal Time. Location: Westside 1, London Road Hemel Hempstead Herefordshire United Kingdom
Reported Earnings • Nov 29First half 2021 earnings released: UK£0.038 loss per shareThe company reported a poor first half result with weaker earnings, revenues and control over expenses. First half 2021 results: Revenue: UK£44.4m (down 56% from 1H 2020). Net loss: UK£14.1m (down 352% from profit in 1H 2020). Over the last 3 years on average, earnings per share has increased by 71% per year but the company’s share price has fallen by 47% per year, which means it is significantly lagging earnings.
Reported Earnings • Sep 28Full year earnings released - €0.02 loss per shareOver the last 12 months the company has reported total losses of UK£7.20m, with losses narrowing by 67% from the prior year. Total revenue was UK£164.7m over the last 12 months, down 18% from the prior year.